Apogee Therapeutics (APGE) Stock Price & Financial Analysis
Apogee Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Apogee Therapeutics
What is the current stock price for APGE?
As of the latest trading session, APGE stock trades at $84.34. The 52-week range is $26.20–$85.94, with a day range of $81.68–$84.90.
What is the P/E ratio for APGE?
The P/E ratio (Price-to-Earnings) for APGE is shown in the Key Statistics section. This valuation metric helps compare Apogee Therapeutics, Inc. to industry peers.
Does APGE pay dividends?
Apogee Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for APGE?
Based on 18 analysts, the consensus for APGE is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of APGE?
Apogee Therapeutics's market capitalization is $5.12B, classifying it as a mid-cap company. Apogee Therapeutics operates in the Healthcare sector within the Biotechnology industry.